![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 33, 25391-25401, August 18, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, November 15, 1999, and in revised form, May 19, 2000
Archaeal zinc-containing ferredoxin from
Sulfolobus sp. strain 7 contains one [3Fe-4S] cluster
(cluster I), one [4Fe-4S] cluster (cluster II), and one isolated zinc
center. Oxidative degradation of this ferredoxin led to the formation
of a stable intermediate with 1 zinc and ~6 iron atoms. The metal
centers of this intermediate were analyzed by electron paramagnetic
resonance (EPR), low temperature resonance Raman, x-ray absorption, and
1H NMR spectroscopies. The spectroscopic data suggest that
(i) cluster II was selectively converted to a cubane
[3Fe-4S]1+ cluster in the intermediate, without forming a
stable radical species, and that (ii) the local metric environments of
cluster I and the isolated zinc site did not change significantly in
the intermediate. It is concluded that the initial step of oxidative degradation of the archaeal zinc-containing ferredoxin is selective conversion of cluster II, generating a novel intermediate containing two [3Fe-4S] clusters and an isolated zinc center. At this stage, significant structural rearrangement of the protein does not occur. We
propose a new scheme for oxidative degradation of dicluster ferredoxins
in which each cluster converts in a stepwise manner, prior to
apoprotein formation, and discuss its structural and evolutionary implications.
Ferredoxins, small iron-sulfur (FeS) proteins in archaea,
serve as water-soluble electron acceptors of acyl-coenzyme A forming 2-oxoacid:ferredoxin oxidoreductase, a key enzyme involved in the
central archaeal metabolic pathways (1-5). The 2.0-Å
resolution x-ray crystal structure
(PDB1 entry 1XER ; Ref. 6) of
ferredoxin from Sulfolobus sp. strain 7 (JCM 10545; optimal
growth conditions, pH 2.5-3 and 80 °C) showed the presence of an
unexpected isolated zinc center, tetrahedrally coordinated by three
nitrogen atoms from histidine residues in the N-terminal extension
region (N Another unexpected result of the crystal structure of air-oxidized
Sulfolobus sp. zinc-containing ferredoxin was the presence of two [3Fe-4S] clusters beside one isolated zinc center
(9) (Fig. 1). The number and type of FeS clusters in this structure are
inconsistent with our previous spectroscopic analysis of the purified
protein, which suggested one [3Fe-4S]1+,0 cluster
(cluster I; E1/2 = Because FeS clusters have a remarkable facility for interconversion
under protein-bound conditions (reviewed in Ref. 14), the significant
discrepancy of the types of FeS clusters of Sulfolobus sp.
zinc-containing ferredoxin in the crystalline and as-isolated states
may represent selective degradation of the cluster II to a [3Fe-4S]
form in vitro. Although the [4Fe-4S] We have recently found conditions where the native 7Fe form of
Sulfolobus sp. ferredoxin (5) is slowly and irreversibly converted to a stable intermediate species under aerobic conditions (10). Herein, we report comparisons of EPR, resonance Raman, XAS, and
1H nuclear magnetic resonance (NMR) analyses of the metal
centers in the native 7Fe and the intermediate forms of
Sulfolobus sp. zinc-containing ferredoxin. Our spectroscopic
data demonstrate the oxidative degradation of cluster II to form a
[3Fe-4S] cluster, yielding a 6Fe-containing intermediate of
zinc-containing ferredoxin. This will be also discussed with respect to
the structure and evolution of a ferredoxin core fold module.
DEAE-Sepharose Fast Flow and Sephadex G-50 gels were purchased
from Amersham Pharmacia Biotech, and NMR-grade D2O was from Wako Pure Chemicals (Tokyo, Japan). Water was purified by the Milli-Q
purification system (Millipore). Other chemicals used in this study
were of analytical grade.
Sulfolobus sp. strain 7 cells (JCM 10545), originally
isolated from Beppu Hot Springs, Japan, were cultivated aerobically and
chemoheterotrophically at pH 2.5-3 and 75-80 °C, and the 7Fe form
of the archaeal ferredoxin was routinely purified as described previously (5, 10). The intermediate form of Sulfolobus sp. ferredoxin was obtained by artificial conversion at pH 5.0 as described
previously (10), after removal of the unconverted 7Fe form by a
DEAE-Sepharose Fast Flow column chromatography (Amersham Pharmacia
Biotech) followed by a Sephadex G-50 column chromatography (Amersham
Pharmacia Biotech). 2-Oxoacid:ferredoxin oxidoreductase of
Sulfolobus sp. strain 7 was purified as described previously (5, 36). 2-Oxoacid:ferredoxin oxidoreductase activity was monitored
with a horse heart cytochrome c reduction assay at 50 °C
using purified ferredoxin an intermediate electron acceptor (2, 5).
Enzymatic reduction of Sulfolobus sp. ferredoxin with the
cognate 2-oxoacid:ferredoxin oxidoreductase was conducted under
anaerobic conditions at 55 °C as described previously (5).
Absorption spectra were recorded using a Hitachi U3210
spectrophotometer or a Beckman DU-7400 spectrophotometer.
Matrix-assisted laser desorption ionization-time of flight mass
spectrometry of purified apoferredoxin (made in distilled water) was
performed by a Finnigan MAT VISION 2000 instrument at an accelerating
potential of 5.0 kV, using a 2,5-dihydroxybenzoic acid matrix. Electron paramagnetic resonance (EPR) measurements were performed using a JEOL
JES-FE3XG spectrometer equipped with an Air Products model LTR-3-110
Heli-Tran cryostat system and a Scientific Instruments series 5500 temperature indicator/controller. Spin concentrations were estimated by
double integration, with 0.1 and 1 mM Cu-EDTA as standards.
The spectral data were processed using KaleidaGraph version 3.05 (Abelbeck Software).
Low temperature resonance Raman spectra were recorded at 77 K using
488.0-nm and 457.9-nm Ar+ laser excitation (500 mW) as
described previously (7, 37). The sample was immersed into a liquid
nitrogen reservoir and the scattered light was collected at 45 degrees
to the incident beam. The spectral slit width was 4 cm Purified zinc-containing ferredoxins in 20 mM potassium
phosphate buffer, pH 6.8, were concentrated by pressure filtration with
an Amicon YM-3 membrane. Further concentration was achieved by placing
the samples under a stream of dry nitrogen gas. The resultant samples
(~2-3 mM), containing 30% (v/v) glycerol, were frozen
in a 24 × 3 × 2-mm polycarbonate cuvette with a Mylar-tape front window for XAS studies. XAS data were collected at Stanford Synchrotron Radiation Laboratory with the SPEAR storage ring operating in a dedicated mode at 3.0 GeV (Table I),
as reported previously (8). EXAFS analysis was performed with the
EXAFSPAK software according to standard procedures (38).
Curve-fitting analysis was performed as described previously (8, 39).
Multiple scattering models, calculated using FEFF version 7.02 (40),
were based on bis(acetato)-bis(imidazole)-zinc(II) (41) or
tetra(imidazole) zinc(II) perchlorate (42).
Spectroscopic Investigation of Selective Cluster
Conversion of Archaeal Zinc-containing Ferredoxin from
Sulfolobus sp. Strain 7*
§,
,
,
,
Department of Biochemistry and Molecular
Biology, Nippon Medical School, Sendagi, Tokyo 113-8602, Japan, the
¶ Department of Chemistry, Rikkyo (St. Paul's) University,
Toshima-ku, Tokyo 171-8501, Japan, the
Department of Chemistry,
Juntendo University, Inba, Chiba 270-1695, Japan, the ** Department of
Molecular Biology, Tokyo University of Pharmacy and Life Science,
Horinouchi, Tokyo 192-0392, Japan, and the
§§ Center for Metalloenzyme Studies and
Department of Chemistry, University of Georgia,
Athens, Georgia 30602-2556
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 of His16, N
2 of His19, and
N
1 of His34) and one O
1 atom from Asp76
in the FeS cluster-binding core fold (Fig. 1). A similar zinc site was
also found in ferredoxin from Thermoplasma acidophilum strain HO-62 that also contained one [3Fe-4S]1+,0
cluster, and one [4Fe-4S]2+,1+ cluster (7). This site was
analyzed by zinc K-edge x-ray absorption spectroscopy (XAS) (8) and was
found to be essentially identical to the zinc site in
Sulfolobus sp. ferredoxin. Thus, these unusual ferredoxins
contain both the conventional FeS clusters and a structurally conserved, isolated zinc center. This new class of bacterial type ferredoxin, isolated from phylogenetically diverse members of several
aerobic and thermoacidophilic archaea, are thus called "zinc-containing ferredoxins" (2, 6-10).
280 mV) and one
[4Fe-4S]2+,1+ cluster (cluster II;
E1/2 =
530 mV) (5). Other archaeal zinc-containing ferredoxins from T. acidophilum (7, 8), Sulfolobus acidocaldarius (11), and Acidianus
ambivalens (formerly Desulfurolobus ambivalens) (12)
also contain one [3Fe-4S] cluster and one [4Fe-4S] cluster, rather
than two [3Fe-4S] clusters. The primary structure of
Sulfolobus sp. ferredoxin showed the presence of seven
cysteines that are arranged in two FeS cluster-binding motifs, one from
the sequence,
Cys45-Leu-Ala-Asp48-Gly-Ser-Cys51
and Cys93-Pro, and the other from the sequence,
Cys55-Pro and
Cys83-Ile-Phe-Cys86-Met-Ala-Cys89
(5, 13). The latter motif provides a typical binding site for a
[4Fe-4S] cluster with complete cysteinyl ligation, although Cys86 does not serve as a ligand to the [3Fe-4S] cluster
II in the crystal structure (Fig. 1).

View larger version (39K):
[in a new window]
Fig. 1.
The 2.0-Å resolution crystal structure of
the 6Fe-containing form of zinc-containing ferredoxin from
Sulfolobus sp. strain 7 (PDB entry 1XER.pdb; Ref. 9),
colored by the temperature factors. The metal centers (zinc,
cluster I, and cluster II) and important residues are labeled, and
-sheet structures are shown transparently in pink. In
this structure, the region with the highest average temperature factors
(blue) is in the vicinity of the [3Fe-4S] cluster II,
especially around Cys86 and Met87, whereas
other part mostly shows lower temperature factors (red). Of
seven cysteine residues, six serve as the ligands to the two FeS
clusters, whereas Cys86 in the vicinity of the [3Fe-4S]
cluster II is exposed to the solvent, as in the case of
Cys11 of D. gigas ferredoxin II (PDB entry,
1FXD.pdb; Ref. 17) (not shown in the figure). The figure was prepared
using Insight II (Molecular Simulations Inc.).
[3Fe-4S]
cluster interconversion is well known in some bacterial type
ferredoxins (14-25) and aconitase (26-29), there is no conclusive
report demonstrating the selective cluster conversion at the cluster II
site in bacterial type dicluster ferredoxins. The most extensive
spectroscopic analyses of oxidative degradation process in dicluster
ferredoxins have been conducted with Azotobacter vinelandii
ferredoxin I with one [3Fe-4S] cluster and one [4Fe-4S] cluster
(30-35). In this instance, it has been proposed that ferricyanide
oxidation results in complete destruction of the [4Fe-4S] cluster, to
produce an intermediate containing only one [3Fe-4S] cluster (cluster
I), en route to complete disruptions of both clusters and ultimately to
unfolded protein (30, 31).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1, and a multiscan averaging technique was employed.
X-ray absorption spectroscopic data collection for iron and zinc
analysis
1H NMR spectra were recorded on using JEOL GSX-400
spectrometer operating at 399.78 MHz Larmor frequency. The NMR sample
was prepared by exchanging the buffer of purified ferredoxin into 10 mM sodium deuterium phosphate buffer, pH 7.5 (pH was
uncorrected), using an Amicon ultrafiltration device with a YM-3
membrane (final concentration, ~3 mM ferredoxin). Sweep
widths of 30 KHz were used for the purified protein. 1H
spectra were recorded with either a slow repetition time (2 s) using
presaturation for water suppression or with a fast repetition time (100 ms) using a super water elimination Fourier transform (super-WEFT) pulse sequence (43) with a relaxation delay (60 ms)
between the
and
/2 pulse sequence for water suppression. The
spectra were calibrated by referencing to the residual HDO signal, assigned to a 4.74-ppm shift at 303 K. The standard JEOL software package was used for data processing.
Protein concentration of purified ferredoxins was measured as described
previously (10). Metal content analyses were carried out by inductively
coupled plasma atomic emission spectrometry with a Seiko SPS 1500 VR
instrument at Tokyo Institute of Technology and a Jobin-Yvon JY 38S
instrument at Rigaku Ltd.
| |
RESULTS |
|---|
|
|
|---|
The typical yield of the purified intermediate obtained from the 7Fe form was ~30% under the conditions described under "Experimental Procedures." The matrix-assisted laser desorption ionization-time of flight mass spectrometry suggested that masses [M + H]1+ of these apoproteins are identical within the experimental error (data not shown). Chemical analysis by inductively coupled plasma atomic emission spectrometry suggested the iron:zinc ratio of 6.9:1.0 mol/mol in the native 7Fe form and 5.6:1.0 mol/mol in the intermediate form.
EPR Properties of the Native 7Fe and Intermediate Forms of
Sulfolobus sp. Ferredoxin--
The 7Fe form of Sulfolobus
sp. ferredoxin elicited a sharp g = 2.02 EPR signal
(0.9-1.0 spin/mol) attributed to a [3Fe-4S]1+ cluster as
reported previously (5, 8) (Fig. 2,
trace A). The intermediate form also elicited a
sharp EPR signal at g = 2.02, detectable up to 20 K,
but with different lineshapes and relaxation behavior. The microwave
power saturation behavior of the EPR signal at 8 K, of the intermediate
form (P1/2 of 36 mW assuming a single
component; P1/2 of 0.7 mW and 110 mW
assuming two components; open squares in Fig.
2B), was also different from that of the native 7Fe form
(P1/2 of 60 mW; closed
squares in Fig. 2B). Under non-saturation
conditions, the spin concentration of the g = 2.02 EPR
signal of the intermediate was estimated to be ~1.7 spin/mol,
indicating the presence of approximately two S = 1/2
[3Fe-4S]1+ clusters. No EPR signals were detected at
temperatures above 35 K, suggesting the absence of a stable
radical species in the air-oxidized intermediate (cf. Refs.
30, 33, and 34).
|
Upon reduction of the native 7Fe form, the sharp g = 2.02 EPR signal attributed to that of a [3Fe-4S]1+
cluster was fully reduced, thus giving rise to a very broad low field
resonance at g ~ 12, which is characteristic of the
reduced S = 2 [3Fe-4S]0 cluster (44)
(Fig. 3, trace A).
A rhombic EPR signal at g = 2.06, 1.94, and 1.90, attributed to the reduced S = 1/2
[4Fe-4S]1+ cluster, was detected. This signal had
additional wings on the high and low field sides of the main EPR signal
(g = 2.11 and 1.85), resulting from magnetic
interactions with the reduced S = 2 [3Fe-4S]0 cluster. These EPR signals could be detected up
to 30 K (data not shown), and no evidence for the presence of a high
multiplicity S = 3/2 [4Fe-4S]1+ cluster
was obtained (Fig. 3, trace A).
|
Reduction of the intermediate under the same conditions resulted in the disappearance of most of the sharp g = 2.02 EPR signal attributed to the S = 1/2 [3Fe-4S]1+ clusters, and the appearance of the broad low field resonance at g = 12 characteristic of the S = 2 [3Fe-4S]0 cluster, as the predominant species (Fig. 3, traces B, C, and D). Several weak and minor resonances, mainly consisting of the remaining S = 1/2 [3Fe-4S]1+ cluster at g = 2.02 and a very weak radical feature at g = 2 of unknown origin, were also reproducibly detected in the g ~ 2 region (<0.1 spin/mol). All these minor species existed in a substoichiometric amount (<0.1 spin/mol), indicating minor heterogeneity in the dithionite-reduced intermediate form.
Resonance Raman Spectroscopy--
Low temperature resonance Raman
spectroscopy has been utilized as a probe for distinguishing between
types of oxidized FeS clusters (16, 45-47). Hence, the properties of
the air-oxidized FeS clusters of Sulfolobus sp. ferredoxin
were investigated by resonance Raman spectroscopy (Fig.
4, A and B). Based
on extensive assignments by Spiro and co-workers (45, 46), it appears
that the [3Fe-4S]1+ cluster of the native 7Fe form
exhibits three primarily Fe-S bridging modes (260, 285, and 347 cm
1) and at least two Fe-S terminal modes
(369 and 385 cm
1) (Fig. 4B).
|
A weak band at 335 cm
1 appears in the native
7Fe form and is assigned to the Fe-S bridging mode of a regular
biological [4Fe-4S]2+ cluster with complete cysteinyl
ligation (46) (Fig. 4A). In Pyrococcus furiosus
4Fe ferredoxin and active aconitase, which contain a [4Fe-4S] cluster
coordinated by one non-cysteinyl and three cysteinyl ligands (16, 48,
49), the equivalent band was shifted to a higher frequency (16). It has
been reported that the resonance Raman spectra for biological
[4Fe-4S]2+ clusters are normally much less intense than
those for biological [3Fe-4S]1+ clusters
(reviewed in Refs. 45 and 47). Relative intensity of the
Fe-S bridging mode of a [4Fe-4S]2+ cluster at
335-cm
1 band in the native 7Fe form of
Sulfolobus sp. ferredoxin (Fig. 4A) is very
similar to that reported for Thermus thermophilus 7Fe
ferredoxin (45, 47). A very weak Fe-S terminal mode at ~249
cm
1 is normally seen for
[4Fe-4S]2+ clusters; however, the signal in this region,
for the 7Fe form of Sulfolobus sp. ferredoxin, is too weak
to analyze. In conjunction with other spectroscopic data reported in
this paper (Figs. 2 and 3), the resonance Raman data of the native 7Fe
form indicate the presence of a [4Fe-4S]2+ cluster, in
addition to a [3Fe-4S]1+ cluster.
The low temperature resonance Raman spectrum at 488.0-nm
Ar+ ion laser excitation of the intermediate form showed
that the [3Fe-4S]1+ cluster also exhibited three Fe-S
bridging modes at 260, 285, and 347 cm
1, and
at least two Fe-S terminal modes at 369 and 385 cm
1 (Fig. 4D). Detection of these
bands in both the native 7Fe (Fig. 4B) and intermediate 6Fe
forms (Fig. 4D) suggests that the [3Fe-4S]1+
core structure is structurally not very different in these two forms.
On the other hand, the weak band primarily associated with the Fe-S
bridging mode at 335 cm
1 of the
[4Fe-4S]2+ cluster of the native 7Fe form, resonantly
enhanced upon 457.9-nm Ar+ ion laser excitation (Fig.
4A), was not detected in the intermediate form (Fig.
4C). These results are consistent with the absence of a
[4Fe-4S]2+ cluster in the intermediate form. It should be
noted that the band at 359 cm
1, resonantly
enhanced upon 457.9-nm Ar+ ion laser excitation (Fig. 4,
A and C), was detected in both forms of
Sulfolobus sp. ferredoxin, whereas the equivalent band was
observed in the 7Fe, but not the 6Fe, form of Mycobacterium smegmatis ferredoxin (37, 50). This indicates that a weak band at
~359 cm
1 cannot be used diagnostically for
the presence of a conventional biological [4Fe-4S]2+ cluster.
X-ray Absorption Spectroscopy--
The zinc K-edge x-ray
absorption spectra of the purified 7Fe and 6Fe forms of
Sulfolobus sp. ferredoxin are very similar (Fig. 5). The absorption edge positions (9663.2 for 7Fe, 9663.3 for 6Fe) for both samples fall at the expected energy
for Zn(II) with all light elements (nitrogen or oxygen) in the
coordination sphere (51,
52).2 The intensity of the
edge is most reminiscent of four-coordinate compounds, and the peak
area of the second XANES peak is not as intense as expected for
tetraimidazole coordination, nor is it as weak as seen in a
ZnO4 compound (51).
|
The presence of a carboxylate ligand results in destructive
interference with the EXAFS multiple-scattering contributions from
outer shell atoms of histidine imidazoles. This interference can be
visualized in the Fourier transform of the data as a decrease in the
~3-Å peak relative to the ~4-Å peak. Previously, we reported that
the 7Fe form of Sulfolobus sp. ferredoxin was best fit
assuming a Zn(imid)3,4(COO
)1
coordination environment with a Zn-O-C bond angle of ~126° (Fit 4, Table II)
(8).3 Similarly, the 6Fe form
can also be fit assuming the same coordination geometry (cf.
Fits 4 and 8, Table II; Fig. 6). The zinc
XAS results clearly show that the zinc site found in the intermediate
is an isolated center having very similar coordination environment to the native 7Fe form. The XAS-determined bond distances and bond angles
of the intermediate are also in agreement with the crystallographically determined Zn-N and Zn-O bond distances (1.96 and 1.90 Å,
respectively) and Zn-O-C angle (~126°) (6).
|
|
The iron K-edge x-ray absorption spectra for the two forms of
Sulfolobus sp. ferredoxin were almost identical (Fig. 5).
Curve-fitting analysis of the native 7Fe form and the stable
intermediate reveals the presence of a 2.25-2.26-Å Fe-S and a
2.71-2.72-Å Fe-Fe interaction (8). The best fit (by goodness-of-fit
values) is obtained from calculated EXAFS for
FeS4Fe2 (Fit 10, Table II). However, the data
can also be fit assuming FeS4Fe2.5 (Fit 11, Table II), as expected for one [3Fe-4S] and one [4Fe-4S] cluster
(8). EXAFS for the 6Fe form (Fig. 6) is best fit assuming
FeS4Fe2 (Fit 13, Table II), as expected for two
[3Fe-4S] clusters. The goodness-of-fit value is lower for
FeS4Fe1 (Fit 12, Table II); however, the
Debye-Waller factor for the Fe-Fe interaction is physically
unreasonable. Similar to the 7Fe form, the data can also be fit
assuming FeS4Fe2.5 (Fit 14, Table II). However,
the Debye-Waller factors indicate that there are on average fewer (or
more disordered) Fe-Fe interactions in the 6Fe form than in the 7Fe
form, as would be expected given the [4Fe-4S]
[3Fe-4S] cluster
conversion. It should be noted that the EXAFS analysis of the
oxidatively degraded 3Fe-containing intermediate and a single crystal
of the native 7Fe form of A. vinelandii ferredoxin I showed
the average Fe-Fe distance of ~2.7 Å (32, 35, 53), similar to the
results obtained here.
1H NMR Spectroscopy--
1H NMR
spectroscopy has been used to detect and assign the
-protons of
cysteine ligand residues coordinated to the FeS centers in some
7Fe-containing ferredoxins (54-57). Bentrop et al. (55) have performed detailed paramagnetic NMR analysis of the native 7Fe
form of another zinc-containing ferredoxin from A. ambivalens, which is 95% identical to Sulfolobus sp.
ferredoxin at the primary structural level (only 5 out of 103 amino
acids are different) (7, 12, 58). Interestingly, the 1H NMR
spectrum of A. ambivalens ferredoxin shows eight major and eight minor hyperfine-shifted resonances, arising from its ligand protons. This unique pattern apparently results from the superposition of typical spectra from a 3Fe- and a 4Fe-containing cluster (55). This
pattern has not been reported for other regular bacterial 7Fe-containing ferredoxins, all of which show only five
hyperfine-shifted resonances in the downfield region (54, 56, 57,
59-62). It has been reported that eight major and eight minor
hyperfine-shifted resonances likely reflect a heterogeneity of one of
the two clusters of A. ambivalens ferredoxin, which does not
simply result from sample impurity (55).
The overall spectral features, chemical shift values, and temperature
dependences of the hyperfine-shifted resonances in the downfield
1H NMR spectrum of native Sulfolobus sp.
ferredoxin (Fig. 7, A, C, and D) are essentially identical to those of
the closely related A. ambivalens ferredoxin. A. ambivalens has complete cysteinyl coordination to both the
[3Fe-4S]1+ cluster and [4Fe-4S]2+ cluster
(55). Eight major signals (C, G, H, J, K, N, O, P) and eight minor
signals (A, B, D, E, F, I, L, M) were detected in the downfield region.
Each of these hyperfine-shifted resonances displays an anti-Curie
temperature dependence, with the exception of major signals, C and H,
and minor signals, D and E, which have Curie-type temperature
dependences (Fig. 7, C and D). Based on the
assignment of the hyperfine-shifted resonances of A. ambivalens ferredoxin (55), major signals C, H, G, and K are
attributed to ligands of the [3Fe-4S]1+ cluster I, and
major signals J, N, O, and P to ligands of the [4Fe-4S]2+
cluster II (Fig. 7, A and C). The sequence
specific-assignment of the cysteine resonances in A. ambivalens ferredoxin (55) also indicates that the major signal
J of the native 7Fe form is attributable to the H
proton of
Cys86, which is located in the [4Fe-4S] cluster II site.
It should be noted that Cys86 is located in the vicinity of
the missing corner (Fe) of the cube at the [3Fe-4S] cluster II site
in the x-ray crystal structure of the 6Fe form of Sulfolobus
sp. ferredoxin (Fig. 1).
|
The overall spectral features and chemical shift values of the
downfield resonances did not change when stored at 5 °C for a short
period (within 1 month). However, storage of the native 7Fe form, under
oxygenic conditions at 5 °C, in NMR tubes for a long term period
resulted in gradual and irreversible changes in the spectrum (Fig.
7B). The relative intensities of major signals J, N, O, and
P gradually decreased in 7 months, whereas the chemical shift values
and relative intensities of other major signals C, H, G, and K,
remained unchanged under these conditions (Fig. 7B). This
process was sluggish and did not go to
completion.4 The low
temperature resonance Raman spectrum of this sample showed a decrease
of the Fe-S bridging mode at 335 cm
1
attributed to the [4Fe-4S]2+ cluster II (Fig.
8B; see also Fig. 4).
|
Concomitant with the decrease of major peaks, J, N, O, and P, several hyperfine-shifted resonances appeared at around 16.0, 21.4, and 24.0-24.6 ppm (Fig. 7B). The chemical shift values of the new peaks at 16.0 ppm (b) and 24.0-24.6 ppm (a) are very similar to the hyperfine-shifted resonances B1 and B4 of ferricyanide-treated dicluster ferredoxin of Thermus thermophilus HB8 (60). The temperature dependence of the new peak a at 24.0-24.6 ppm in the downfield spectrum of Sulfolobus sp. ferredoxin suggested splitting into two peaks, a1 and a2, at 30 °C (Fig. 7E), as previously observed for the downfield-shifted resonances at around 24.5 ppm of the 3Fe form of P. furiosus monocluster ferredoxin (63-65). In addition, the new signal a1 at 24.0-24.6 ppm showed Curie-type temperature dependence (Fig. 7E), as observed with the major signal pair C and H and minor signal pair D and E, which are attributed to one ligand (CysIV) of a [3Fe-4S] cluster domain (55) (Fig. 7, C and D). The details of the sequence-specific assignments of the new hyperfine-shifted resonances are the subject of future analysis, and their correlation with the minor peaks observed in the native 7Fe form remain unclear at this stage. However, some of these resonances (such as signal a) probably belong to a [3Fe-4S] cluster domain and are in line with the increase of the EPR signal intensity at g = 2.02 (data not shown; see Fig. 2).
Taken together, these data suggest that the [4Fe-4S] cluster II in the native 7Fe form is less stable to oxidative degradation than the [3Fe-4S] cluster I, and that the [4Fe-4S]2+ cluster II is gradually and selectively converted to a corresponding cubane [3Fe-4S]1+ cluster II, whereas the [3Fe-4S] cluster I remains essentially unchanged under the applied conditions. Further 1H NMR analysis is underway to reveal the sequence-specific assignments of the new hyperfine-shifted resonances and the electronic structure of the two [3Fe-4S] clusters in the 6Fe-containing intermediate form.
Biochemical Properties--
Archaeal zinc-containing ferredoxins
have been shown to serve as water-soluble electron acceptors of
acyl-coenzyme A forming 2-oxoacid:ferredoxin oxidoreductase, a key
enzyme involved in the central archaeal metabolic pathways (2, 3, 5, 7, 12). Previous enzymatic reduction of the native 7Fe form by Sulfolobus sp. 2-oxoacid:ferredoxin oxidoreductase reduced
only the [3Fe-4S] cluster I, whereas the [4Fe-4S] cluster II with a lower midpoint redox potential remained in the oxidized state during
the steady state (5). The specific activity of the cognate 2-oxoacid:ferredoxin oxidoreductase in the presence of 4 mM
2-oxoglutarate, 50 µM coenzyme A, and 23 µg of the
6Fe-containing intermediate form at 50 °C was 55 µmol/min/mg, only
slightly lower than that measured with the native 7Fe form under the
same conditions (60 µmol/min/mg) (5, 36). Thus, the reactivity with
the cognate oxidoreductase was not lost after the [4Fe-4S]
[3Fe-4S] cluster conversion. Enzymatic reduction of the 6Fe form with
a catalytic amount of the 2-oxoacid:ferredoxin oxidoreductase (8.6 µg/ml) in the presence of 4 mM 2-oxoglutarate and 0.5 mM coenzyme A during the steady-state turnover of the
oxidoreductase under anaerobic conditions at 55 °C caused bleaching
of the g = 2.02 EPR signal attributed to the
[3Fe-4S]1+ clusters (see Fig. 3) by ~95% in 30 min,
with concomitant formation of the broad low field resonance at
g ~ 12, which is indicative of the S = 2 [3Fe-4S]0 clusters (data not shown). This indicates
that the two [3Fe-4S] clusters, i.e. both clusters I and
II, of the 6Fe form can be reduced enzymatically by the cognate
oxidoreductase under the applied conditions, due to the change of
electron distributions within the reduced ferredoxin molecule by
relative redox potential upshift of the cluster II upon the selective
cluster conversion.
| |
DISCUSSION |
|---|
|
|
|---|
The present spectroscopic investigation indicates that the initial
step of oxidative degradation of the native 7Fe form of Sulfolobus sp. zinc-containing ferredoxin, at fairly acidic
or neutral pH, is a selective conversion of the [4Fe-4S] cluster II
to a [3Fe-4S] cluster. This degradation pathway results in a stable
6Fe-containing intermediate with one isolated zinc center and two
[3Fe-4S] clusters, en route to complete protein unfolding. Although
the selective interconversion of a [4Fe-4S]
[3Fe-4S] cluster at
the cluster I site has been well established in some bacterial
ferredoxins (14-25), this novel intermediate is unique in that its
formation is triggered by selective cluster conversion at the cluster
II site, rather than complete destruction of the cluster. The local
metric environments of the [3Fe-4S] cluster I and isolated zinc site
in the intermediate form do not change significantly as compared with
those in the native 7Fe form, indicating that structural rearrangement
of the whole molecule does not occur at the initial step of oxidative
degradation. The ability of the intermediate to accept electrons
transferred from the cognate 2-oxoacid:ferredoxin oxidoreductase is
also maintained at this stage.
Correlation with the X-ray Crystal Structure of the 6Fe Form of the Sulfolobus Ferredoxin-- The spectroscopic properties of the stable intermediate form of Sulfolobus sp. ferredoxin are consistent with the structural features observed for the 2.0-Å resolution crystal structure of the 6Fe form (6, 9). In this structure, the [3Fe-4S] cluster I is coordinated by three cysteinyl ligands contributed from Cys45, Cys51, and Cys93, and the [3Fe-4S] cluster II by another three cysteinyl ligands contributed from Cys55, Cys83, and Cys89 (9) (Fig. 1). The two [3Fe-4S] clusters are separated by a crystallographic, center-to-center distance of 12.0 Å, which is similar to that observed in some regular 7Fe- and 8Fe-containing dicluster ferredoxins. The second cysteine residue (Cys86) in the -Cys83-Xaa-Xaa-Cys86-Xaa-Xaa-Cys89-Xaa-Xaa-Xaa-Cys93-Pro- motif is located in the vicinity of the missing corner (Fe) of the cluster II cube, and its side chain is exposed to the solvent, away from cluster II (Fig. 1). A similar observation has been reported for the non-ligating cysteinyl residue (Cys11) in the D. gigas ferredoxin II structure with a single cubane [3Fe-4S] cluster (PDB entry 1FXD.pdb; Ref. 17). The equivalent residue (Cys13) of the closely related 4Fe-containing ferredoxin from Thermotoga maritima (PDB entry 1VJW.pdb; Ref. 66) serves as a ligand to the [4Fe-4S] cluster.
The electron density for Cys86 is lower than that of other cysteinyl ligand residues in the crystal structure. Additionally, the average temperature factors for the region surrounding cluster II (~24 Å2, on average), especially Cys86 and Met87 (>30 Å2), are markedly higher than those for the region surrounding cluster I (~15 Å2) (9) (Fig. 1). These observations are consistent with the present spectroscopic analyses indicating the structural similarity of the native 7Fe form and the stable intermediate, and suggest that the selective cluster conversion at the cluster II site is a local event. In the crystal structure, the polypeptide conformation in the vicinity of the cubane [3Fe-4S] cluster II and Cys86 was reported to be intermediate between the [3Fe-4S] and [4Fe-4S] cluster conformations (9). It is likely that the peptide backbone conformation in vicinity of Cys86 and Met87 may be somewhat perturbed upon formation of the 6Fe-containing intermediate by oxidative degradation.5
Based on these considerations, we suggest that oxidative degradation of Sulfolobus sp. zinc-containing ferredoxin is initiated at the [4Fe-4S] cluster II site. As a result of this initial degradation step, the iron atom bound to Cys86 is released, forming a structurally interconvertible cubane [3Fe-4S] cluster II. Concomitant with the release of iron is a perturbation of the peptide backbone in the vicinity of Cys86-Met87 and rotation of the Cys86 side chain to solvent, away from the cluster (see Fig. 1). At this stage, no significant structural rearrangement of the entire molecule occurs. Further sluggish oxidative degradation of the two [3Fe-4S] clusters eventually leads to protein unfolding of the ferredoxin core fold and accumulation of apoprotein (10), and may involve other short-lived intermediates not yet characterized.
Oxidative Degradation of Two FeS Clusters in Bacterial Type Dicluster Ferredoxins-- The reaction of the wild-type A. vinelandii ferredoxin I with an excess of ferricyanide is a more complicated oxidative degradation, leading to formation of an unusual intermediate with a three-electron oxidation at sulfur sites (30, 31, 33, 34). Site-directed mutagenesis has suggested that formation of the latter species requires the presence of non-ligating Cys24 in the vicinity of a cluster sulfide (33). The difference between the oxidative degradation of ferredoxin from A. vinelandii and Sulfolobus sp. strain 7 is likely to reflect the differences in their cluster surroundings, i.e. the absence of the equivalent cysteine residue in the archaeal ferredoxin core fold domain (Fig. 1).
An analogous 6Fe-containing ferredoxin species has been isolated from
M. smegmatis (37, 50) and similar hyperfine-shifted resonances appear in the downfield 1H NMR spectra of
ferricyanide-treated ferredoxins from M. smegmatis, Pseudomonas ovalis, and T. thermophilus (59-61).
These observations lend credence to our suggestion that a common step
in the oxidative degradation pathway, of regular bacterial type
dicluster ferredoxins, is the formation of an intermediate containing
two [3Fe-4S] clusters, as illustrated in Fig.
9. In some less stable dicluster
ferredoxins, such an intermediate form could be detected only
transiently. In other words, detection of this intermediate might
depend on the overall structural rigidity of the ferredoxin core fold
and/or the cluster surroundings.
|
Structural and Evolutionary Implications--
The polypeptide
backbone structure of a bacterial type ferredoxin exhibits a pseudo
two-fold symmetry regardless of the number of bound FeS clusters. It
has been proposed that the distorted two-fold symmetrical structure has
been derived from a putative common ancestor as a result of early gene
duplication event, and that the cluster I is strictly conserved in all
bacterial type monocluster and dicluster ferredoxins reported so far
(5, 22, 67). There is no monocluster ferredoxin with a cluster bound only to the cluster II site, implying that the two cluster binding sites in a ferredoxin core fold are evolutionary not equivalent (5,
67). The selective interconversion of a [4Fe-4S]
[3Fe-4S] cluster at the cluster I site has been well established in some bacterial ferredoxins (14-25), but this was not demonstrated at the
cluster II site. Our results indicate that oxidative degradation of the
cluster II site in dicluster ferredoxins probably follow the same
chemistry with a general structural rule: The missing corner (Fe) of a
biological [4Fe-4S] cube is associated with either replacement
(e.g. CysII, Asp), or tilting away to solvent,
of the second cysteine residue (CysII) in the
-CysI-Xaa-Xaa-CysII-Xaa-Xaa-CysIII-Xaa-Xaa-Xaa-CysIV-(Pro)-
motif (see Figs. 1 and 9). Although it is currently unclear why this
particular site is the most sensitive target for oxidative damage, we
expect that increased stability of oxygen-labile bacterial type
ferredoxins against oxidant (such as molecular oxygen or ferricyanide)
could be conferred by introducing appropriate mutations to the
polypeptide region in the vicinity of CysII.
A ferredoxin core fold of a bacterial type ferredoxin represents a [3Fe-4S]/[4Fe-4S] cluster-binding module in biological systems, and can be found in various simple and complex electron transfer proteins as a cluster-binding subunit and/or domain (14, 22). To the best of our knowledge, there are only a few instances of electron transfer proteins which have a [3Fe-4S] cluster at the cluster II site of the module. These include an unusual 7Fe-containing ferredoxin from a hyperthermophilic archaeon, Pyrobaculum islandicum (68) and the C-terminal domain of the cluster-binding subunit (subunit B) of some respiratory fumarate reductase and succinate dehydrogenase complexes (69-71). In all cases, the second cysteine residue (CysII) in the -CysI-Xaa-Xaa-CysII-Xaa-Xaa-CysIII-Xaa-Xaa-Xaa-CysIV-(Pro)- motif is replaced by a non-cysteine residue such as Asp, Val, Ile, and Ala. In Escherichia coli respiratory fumarate complex, this might have afforded reduction of the [3Fe-4S] cluster II directly by proximal menaquinol (69). In the native 7Fe form of archaeal zinc-containing ferredoxins, the [4Fe-4S] cluster II is not reduced by the cognate 2-oxoacid:ferredoxin oxidoreductase (5, 7, 12), although the [3Fe-4S] cluster II of the 6Fe intermediate form can be reduced enzymatically by the oxidoreductase. Hence, the apparent effect of these amino acid replacement at the cluster II site is to modulate electron distributions within a reduced ferredoxin module by upshift of the relative redox potential of the cluster, because a [3Fe-4S]1+/0 cluster generally has a higher midpoint redox potential than a [4Fe-4S]2+/1+ cluster in biological systems (22). Nevertheless, the cluster conversion at the cluster II site by a single amino acid replacement seems to be not very favored in the course of molecular evolution of a ferredoxin core fold module, which may be related to the overall stability of the polypeptide backbone.
It is known that a ferredoxin core fold module of a bacterial type
ferredoxin contains only a few secondary structural elements (5, 22)
(see Fig. 1). The FeS cluster binding apparently contributes to the
overall protein stability of the module, but the details of structural
and thermodynamical roles of a metal cofactor in protein folding and
unfolding reactions are little known (72, 73). Recent multidimensional
heteronuclear NMR analysis of a partially unfolded high potential
iron-sulfur protein under severe denaturing conditions indicated that
its [4Fe-4S] cluster plays a decisive role in determining the
resulting ordered structure, and that the backbone mobility increases
with the structural indetermination (74). All the present results are
also consistent with the primary role of an FeS cluster in retaining
the native-like ordered structure of the ferredoxin core fold module
(Figs. 1 and 9). We therefore suggest that the cluster I site of a
ferredoxin core fold module is strictly conserved in biological systems
not only because of the functional importance in electron transfer (5),
but also the structural importance as a possible nucleation site of the
folding of the module that shifts equilibrium toward a native-like
ordered structure presumably by forming the Fe-S(Cys) bonds in
vivo. The cluster II site is less conserved in the ferredoxin core
module (5, 22, 67), but our results indicate that the native-like
ordered structure of the cluster II site is maintained regardless of
the type of an FeS cluster ([4Fe-4S] versus [3Fe-4S]) whenever a protein-bound cluster is present (Fig. 9).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Prof. I. Bertini (University of Florence) and Prof. G. N. La Mar (University of California, Davis) for their helpful advice for paramagnetic NMR analyses of ferredoxins, and Prof. M. K. Johnson (University of Georgia), Prof. T. Oshima (Tokyo University of Pharmacy and Life Science), and Prof. T. Nishino (Nippon Medical School) for discussion. We also thank Dr. H. Ikezawa (Finnigan MAT Instruments, Inc.) for mass measurement and Dr. N. Wakiya (Tokyo Institute of Technology) and Dr. H. Daidohji (Rigaku Ltd.) for the metal content analyses by the inductively coupled plasma atomic emission spectrometry. We acknowledge Dr. Christina M. V. Stålhandske for collecting some of the XAS data.
| |
FOOTNOTES |
|---|
* This work was supported in part by Grant-in-aid 11169237 for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture of Japan (to T. I.) and by National Institutes of Health Grant GM 42025 (to R. A. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom all correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan. Tel.: 81-3-3822-2131 (ext. 5216); Fax: 81-3-5685-3054; E-mail: iwasaki/biochem@om.nms.ac.jp.

Present address: Dept. of Bioengineering, Nagaoka University of
Technology, Nagaoka, Niigata 940-2188, Japan.
¶¶ Supported by National Science Foundation Research Training Group Award DIR 90-14281 (to the Center for Metalloenzyme Studies).
Published, JBC Papers in Press, May 24, 2000, DOI 10.1074/jbc.M909243199
2 Edge position energies were calculated by determining the maxima of the first derivative of the absorption edge.
3 The number of imidazoles from this analysis is not absolute and probably depends on the exact geometry enforced on the carboxylate ligand.
4
In Sulfolobus sp. zinc-containing
ferredoxin, the formation of the 6Fe-containing intermediate is very
slow at around neutral pH, which is the main reason why the equivalent
intermediate escaped detection in the previous 1H NMR
analysis of A. ambivalens ferredoxin (55). This most likely correlates with the local structural rigidity and/or the complete cysteinyl ligations of the cluster II site in Sulfolobus sp.
ferredoxin (see "Discussion"). In this connection, it should be
noted that the Asp14
Cys mutant of D. africanus ferredoxin III showed the presence of two
[4Fe-4S]2+,1+ clusters, and, unlike in native ferredoxin
III, the [4Fe-4S]
[3Fe-4S] cluster interconversion reaction was
sluggish and did not go to completion (19).
5 Preliminary computer modeling analysis by using a SYBYL molecular modeling software (TRIPOS Associates, Inc.) also suggested that simple rotation of the Cys86 side chain did not allow appropriate coordination of this residue to the missing corner (Fe) of a structurally restrained biological [4Fe-4S] cluster introduced and superimposed to the [3Fe-4S] cluster II of Sulfolobus sp. ferredoxin (T. Iwasaki, K. Tomuro, Y. Hayashi-Iwasaki, and T. Oshima, unpublished results).
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PDB, Protein Data Bank; EXAFS, extended x-ray absorption fine structure; XAS, x-ray absorption spectroscopy; W, watt(s); CAPS, 3-(cyclohexylamino)propanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Kerscher, L., and Oesterhelt, D. (1977) FEBS Lett. 83, 197-201 |
| 2. | Kerscher, L., Nowitzki, S., and Oesterhelt, D. (1982) Eur. J. Biochem. 128, 223-230 |
| 3. | Kerscher, L., and Oesterhelt, D. (1982) Trends Biochem. Sci. 7, 371-374 |
| 4. | Adams, M. W. W. (1994) FEMS Microbiol. Rev. 15, 261-277 |
| 5. | Iwasaki, T., Wakagi, T., Isogai, Y., Tanaka, K., Iizuka, T., and Oshima, T. (1994) J. Biol. Chem. 269, 29444-29450 |
| 6. | Fujii, T., Hata, Y., Wakagi, T., Tanaka, N., and Oshima, T. (1996) Nat. Struct. Biol. 3, 834-837 |
| 7. | Iwasaki, T., Suzuki, T., Kon, T., Imai, T., Urushiyama, A., Ohmori, D., and Oshima, T. (1997) J. Biol. Chem. 272, 3453-3458 |
| 8. | Cosper, N. J., Stålhandske, C. M. V., Iwasaki, H., Oshima, T., Scott, R. A., and Iwasaki, T. (1999) J. Biol. Chem. 274, 23160-23168 |
| 9. | Fujii, T., Hata, Y., Oozeki, M., Moriyama, H., Wakagi, T., Tanaka, N., and Oshima, T. (1997) Biochemistry 36, 1505-1513 |
| 10. | Iwasaki, T., and Oshima, T. (1997) FEBS Lett. 417, 223-226 |
| 11. | Breton, J. L., Duff, J. L. C., Butt, J. N., Armstrong, F. A., George, S. J., Pétillot, Y., Forest, E., Schäfer, G., and Thomson, A. J. (1995) Eur. J. Biochem. 233, 937-946 |
| 12. | Teixeira, M., Batista, R., Campos, A. P., Gomes, C., Mendes, J., Pacheco, I., Anemüller, S., and Hagen, W. R. (1995) Eur. J. Biochem. 227, 322-327 |
| 13. | Wakagi, T., Fujii, T., and Oshima, T. (1996) Biochem. Biophys. Res. Commun. 225, 489-493 |
| 14. | Beinert, H., Holm, R. H., and Münck, E. (1997) Science 277, 653-659 |
| 15. | Moura, J. J. G., Moura, I., Kent, T. A., Lipscomb, J. D., Huynh, B.-H., LeGall, J., Xavier, A. V., and Münck, E. (1982) J. Biol. Chem. 257, 6259-6267 |
| 16. | Conover, R. C., Kowal, A. T., Fu, W., Park, J.-B., Aono, S., Adams, M. W. W., and Johnson, M. K. (1990) J. Biol. Chem. 265, 8533-8541 |
| 17. | Kissinger, C. R., Sieker, L. C., Adman, E. T., and Jensen, L. H. (1991) J. Mol. Biol. 219, 693-715 |
| 18. | Armstrong, F. A., Butt, J. N., George, S. J., Hatchikian, E. C., and Thomson, A. J. (1989) FEBS Lett. 259, 15-18 |
| 19. | George, S. J., Armstrong, F. A., Hatchikian, E. C., and Thomson, A. J. (1989) Biochem. J. 264, 275-284 |
| 20. | Butt, J. N., Armstrong, F. A., Breton, J., George, S. J., Thomson, A. J., and Hatchikian, E. C. (1991) J. Am. Chem. Soc. 113, 6663-6670 |
| 21. | Armstrong, F. A. (1992) Adv. Inorg. Chem. 38, 117-163 |
| 22. | Cammack, R. (1992) Adv. Inorg. Chem. 38, 281-322 |
| 23. | Bertini, I., Briganti, F., Calzolai, L., Messori, L., and Scozzafava, A. (1993) FEBS Lett. 332, 268-272 |
| 24. | Butt, J. N., Fawcett, S. E. J., Breton, J., Thomson, A. J., and Armstrong, F. A. (1997) J. Am. Chem. Soc. 119, 9729-9737 |
| 25. | Moura, J. J. G., Macedo, A. L., and Palma, P. N. (1994) Methods Enzymol. 243, 165-188 |
| 26. | Beinert, H., Emptage, M. H., Dreyer, J. L., Scott, R. A., Hahn, J. E., Hodgson, K. O., and Thomson, A. J. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 393-396 |
| 27. | Beinert, H., and Kennedy, M. C. (1989) Eur. J. Biochem. 186, 5-15 |
| 28. | Kennedy, M. C., and Stout, C. D. (1992) Adv. Inorg. Chem. 38, 323-339 |
| 29. | Lauble, H., Kennedy, M. C., Beinert, H., and Stout, C. D. (1994) J. Mol. Biol. 237, 437-451 |
| 30. | Morgan, T. V., Stephens, P. J., Devlin, F., Stout, C. D., Melis, K. A., and Burgess, B. K. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 1931-1935 |
| 31. | Morgan, T. V., Stephens, P. J., Devlin, F., Burgess, B. K., and Stout, C. D. (1985) FEBS Lett. 183, 206-210 |
| 32. | Stephens, P. J., Morgan, T. V., Devlin, F., Penner-Hahn, J. E., Hodgson, K. O., Scott, R. A., Stout, C. D., and Burgess, B. K. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 5661-5665 |
| 33. | Iismaa, S. E., Vázquez, A. E., Jensen, G. M., Stephens, P. J., Butt, J. N., Armstrong, F. A., and Burgess, B. K. (1991) J. Biol. Chem. 266, 21563-21571 |
| 34. | Hu, Z., Jollie, D., Burgess, B. K., Stephens, P. J., and Münck, E. (1994) Biochemistry 33, 14475-14485 |
| 35. | Scott, R. A., Penner-Hahn, J. E., Hodgson, K. O., Beinert, H., and Stout, C. D. (1984) in EXAFS and Near Edge Structure III: Proceedings of an International Conference, Stanford, CA, July 16-20, 1984 (Hodgson, K. O. , Hedman, B. , and Penner-Hahn, J. E., eds) , pp. 105-110, Springer-Verlag, Berlin |
| 36. | Zhang, Q., Iwasaki, T., Wakagi, T., and Oshima, T. (1996) J. Biochem. (Tokyo) 120, 587-599 |
| 37. | Imai, T., Urushiyama, A., Saito, H., Sakamoto, Y., Ota, K., and Ohmori, D. (1995) FEBS Lett. 368, 23-26 |
| 38. | Scott, R. A. (1985) Methods Enzymol. 117, 414-459 |
| 39. | Cosper, N. J., Stålhandske, C. M. V., Saari, R. E., Hausinger, R. P., and Scott, R. A. (1999) J. Biol. Inorg. Chem. 4, 122-129 |
| 40. | Zabinsky, S. I., Rehr, J. J., Ankudinov, A., Albers, R. C., and Eller, M. J. (1995) Phys. Rev. B 52, 2995 |
| 41. | Harrocks, W. D., Holmquist, J. N. I. B., and Thompson, J. S. (1980) J. Inorg. Biochem. 12, 131 |
| 42. | Bear, C. A., Duggan, K. A., and Freeman, H. C. (1975) Acta Crystallogr. Sect. B Struct. Sci 31, 2713 |
| 43. | Inubushi, T., and Becker, E. D. (1983) J. Magn. Reson. 51, 128-133 |
| 44. | Johnson, M. K., Bennett, D. E., Fee, J. A., and Sweeney, W. V. (1987) Biochim. Biophys. Acta 911, 81-94 |
| 45. | Johnson, M. K., Czernuszewicz, R. C., Spiro, T. G., Fee, J. A., and Sweeney, W. V. (1983) J. Am. Chem. Soc. 105, 6671-6678 |
| 46. | Czernuszewicz, R. S., Macor, K. A., Johnson, M. K., Gewirth, A., and Spiro, T. G. (1987) J. Am. Chem. Soc. 109, 7178-7187 |
| 47. | Spiro, T. G., and Czernuszewicz, R. S. (1995) Methods Enzymol. 246, 416-460 |
| 48. | Park, J.-B., Fan, C., Hoffman, B. M., and Adams, M. W. W. (1991) J. Biol. Chem. 266, 19351-19356 |
| 49. | Calzolai, L., Gorst, C. M., Zhao, Z.-H., Teng, Q., Adams, M. W. W., and La Mar, G. N. (1995) Biochemistry 34, 11373-11384 |
| 50. | Imai, T., Kamata, K., Saito, H., and Urushiyama, A. (1995) Bull. Chem. Soc. Jpn. 68, 2923-2930 |
| 51. | Jacquamet, L. D. A., Adrait, A., Hazeman, J.-L., Latour, J.-M., and Michaud-Soret, I. (1998) Biochemistry 37, 2564-2571 |
| 52. | Clark-Baldwin, K., Tierney, D. L., Govindaswamy, N., Gruff, E. S., Kim, C., Berg, J., Koch, S. A., and Penner-Hahn, J. E. (1998) J. Am. Chem. Soc. 120, 8401-8409 |
| 53. | Scott, R. A., Kazmi, S. A., Beinert, H., Emptage, M. H., Hahn, J. E., Hodgson, K. O., Stout, C. D., and Thomson, A. J. (1983) Inorg. Chim. Acta 79, 142 |
| 54. | Cheng, H., Grohmann, K., and Sweeney, W. V. (1992) J. Biol. Chem. 267, 8073-8080 |
| 55. | Bentrop, D., Bertini, I., Luchinat, C., Mendes, J., Piccioli, M., and Teixeira, M. (1996) Eur. J. Biochem. 236, 92-99 |
| 56. | Bertini, I., Dikiy, A., Luchinat, C., Macinai, R., Viezzoli, M. S., and Vincenzini, M. (1997) Biochemistry 36, 3570-3579 |
| 57. | Aono, S., Bentrop, D., Bertini, I., Donaire, A., Luchinat, C., N |